Ticker LaunchReverse merger · Completed · TRAW
Trawsfynydd Therapeutics, Inc.
Reverse merger with Onconova Therapeutics, Inc. (ONTX)
Trawsfynydd Therapeutics, Inc. merged into Onconova Therapeutics, Inc. (ONTX), a clinical-stage oncology biotech, in a reverse merger that takes the private company public. The agreement was signed and the deal closed on the same day, Apr 1, 2024. The combined company trades as Traws Pharma, Inc. (TRAW) on Nasdaq.
Traws Pharma, Inc. develops antivirals for influenza and COVID-19, including viroksavir and travaltrelvir, together with the CDK4/6 inhibitor narazaciclib for endometrial cancer. It is led by former Trawsfynydd executives and an OrbiMed-chaired board.
- Status
- Completed
- Private company
- Trawsfynydd Therapeutics, Inc.
- Public company
- Onconova Therapeutics, Inc. (ONTX)
- Public company business before
- clinical-stage oncology biotech
- Announced
- Signed and closed the same day
- Closed
- Apr 1, 2024
- Combined company
- Traws Pharma, Inc. (TRAW)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Concurrent financing and investors
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Announcement 8-K Apr 4, 2024
- Announcement press release
- Closing 8-K Apr 4, 2024
- All filings on EDGAR CIK 1130598
Other completed reverse mergers
- VinHMS Pte. Ltd.into Vemanti Group, Inc. · Apr 1, 2024
- Serina Therapeutics, Inc.into AgeX Therapeutics, Inc. · Mar 26, 2024
- Q32 Bio Inc.into Homology Medicines, Inc. · Mar 25, 2024
- LENZ Therapeutics (LENZ OpCo)into Graphite Bio, Inc. · Mar 21, 2024
- Emergent Health Corp.into Resonate Blends, Inc. · Mar 14, 2024
- XTI Aircraft Companyinto Inpixon · Mar 12, 2024